This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Elbion AG (inflammation and CNS therapeutics) has completed its first venture round, bringing in €35mm ($44mm) for the company. 3i, Burrill & Co., and DVC Deutsche Venture Capital co-led the financing and were joined by AGF Private Equity, Quintiles PharmaBio Development, BayTech Venture Capital, Marubeni Corp., TVM Techno Venture Management, Temasek Holdings, and Mitsubishi Corp.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?